The pharmaceutical landscape for diabetes is evolving, and transdermal GLP-1 delivery systems represent a promising breakthrough. Unlike subcutaneous injections, this method offers a more convenient way to provide https://phoenixykzg020437.vblogetin.com/47065704/glp-1-patches-a-novel-approach-to-diabetes-control